Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
O ITM Group anunciou hoje que sua subsidiária ITG GmbH fechou, com sucesso, um acordo de in-licensing (licenciamento recebido) do DOTA-Zoledronato,...
ITM Group anunció hoy que su subsidiaria ITG GmbH ha obtenido la licencia de DOTA-Zoledronate, un agente de próxima generación para terapia y...
- Isotope Technologies Garching GmbH anuncia la licencia de DOTA-Zoledronate para la teranóstica de radionucleido destinada ósea para metástasis de...
ITM Group a annoncé aujourd'hui que sa filiale ITG GmbH a acquis avec succès la licence de DOTA-Zoledronate, un agent théranostique de nouvelle...
The ITM Group announced today that its subsidiary ITG GmbH has successfully in-licensed DOTA-Zoledronate, a next generation theranostic agent for...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.